Outcome Prediction for Patients with Bipolar Disorder Using Prodromal and Onset Data †
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Population
2.2. Clinical Features
2.3. Temporal Data Representation
2.4. Outcome Variables
2.5. Deep Neural Network
2.6. Training and Testing of the DNN
2.7. Support Vector Machine
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- McMahon, F.J. Prediction of treatment outcomes in psychiatry—Where do we stand? Dialog. Clin. Neurosci. 2014, 16, 455–464. [Google Scholar] [CrossRef] [PubMed]
- Treuer, T.; Tohen, M. Predicting the course and outcome of bipolar disorder: A review. Eur. Psychiatry 2010, 25, 328–333. [Google Scholar] [CrossRef]
- Tondo, L.; Visioli, C.; Preti, A.; Baldessarini, R.J. Bipolar disorders following initial depression: Modeling predictive clinical factors. J. Affect. Disord. 2014, 167, 44–49. [Google Scholar] [CrossRef] [PubMed]
- Evans, T.S.; Berkman, N.; Brown, C.; Gaynes, B.; Weber, R.P. Disparities within Serious Mental Illness; Agency for Healthcare Research and Quality (US): Rockville, MD, USA, 2016. [Google Scholar]
- Jamei, M.; Nisnevich, A.; Wetchler, E.; Sudat, S.; Liu, E. Predicting all-cause risk of 30-day hospital readmission using artificial neural networks. PLoS ONE 2017, 12, e0181173. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lassale, C.; Gunter, M.J.; Romaguera, D.; Peelen, L.M.; Van Der Schouw, Y.T.; Beulens, J.W.J.; Freisling, H.; Muller, D.C.; Ferrari, P.; Huybrechts, I.; et al. Diet Quality Scores and Prediction of All-Cause, Cardiovascular and Cancer Mortality in a Pan-European Cohort Study. PLoS ONE 2016, 11, e0159025. [Google Scholar] [CrossRef] [PubMed]
- Upshaw, J.N.; Konstam, M.A.; van Klaveren, D.; Noubary, F.; Huggins, G.S.; Kent, D.M. Multistate Model to Predict Heart Failure Hospitalizations and All-Cause Mortality in Outpatients With Heart Failure With Reduced Ejection Fraction. Circ. Hear. Fail. 2016, 9, e003146. [Google Scholar] [CrossRef] [Green Version]
- Wan, E.Y.F.; Fong, D.Y.T.; Fung, C.S.C.; Yu, Y.T.E.; Chin, W.Y.; Chan, A.K.C.; Lam, C.L.K. Prediction of five-year all-cause mortality in Chinese patients with type 2 diabetes mellitus—A population-based retrospective cohort study. J. Diabetes Its Complicat. 2017, 31, 939–944. [Google Scholar] [CrossRef] [PubMed]
- Kane, K.D.; Yochim, B.P.; Lichtenberg, P.A. Depressive symptoms and cognitive impairment predict all-cause mortality in long-term care residents. Psychol. Aging 2010, 25, 446–452. [Google Scholar] [CrossRef] [Green Version]
- Keyes, C.L.M.; Simoes, E.J. To Flourish or Not: Positive Mental Health and All-Cause Mortality. Am. J. Public Health 2012, 102, 2164–2172. [Google Scholar] [CrossRef]
- Kripalani, S.; Theobald, C.N.; Anctil, B.; Vasilevskis, E.E. Reducing Hospital Readmission Rates: Current Strategies and Future Directions. Annu. Rev. Med. 2014, 65, 471–485. [Google Scholar] [CrossRef] [Green Version]
- Pradier, M.F.; Hughes, M.C.; Jr, T.H.M.; Barroilhet, S.A.; Doshi-Velez, F.; Perlis, R.H. Predicting change in diagnosis from major depression to bipolar disorder after antidepressant initiation. Neuropsychopharmacology 2020, 46, 455–461. [Google Scholar] [CrossRef] [PubMed]
- Bennett, C.C.; Ross, M.K.; Baek, E.; Kim, D.; Leow, A.D. Predicting clinically relevant changes in bipolar disorder outside the clinic walls based on pervasive technology interactions via smartphone typing dynamics. Pervasive Mob. Comput. 2022, 83, 101598. [Google Scholar] [CrossRef]
- Busch, A.B.; Neelon, B.; Zelevinsky, K.; He, Y.; Normand, S.-L.T. Accurately Predicting Bipolar Disorder Mood Outcomes. Med. Care 2012, 50, 311–319. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Thieme, A.; Belgrave, D.; Doherty, G. Machine Learning in Mental Health: A Systematic Review of the HCI Literature to Support the Development of Effective and Implementable ML Systems. ACM Trans. Comput.-Hum. Interact. 2020, 27, 34. [Google Scholar] [CrossRef]
- LeCun, Y.; Bengio, Y.; Hinton, G. Deep learning. Nature 2015, 521, 436–444. [Google Scholar] [CrossRef]
- The U.S. Department of Veterans Affairs. Available online: https://www.va.gov/health/ (accessed on 11 January 2023).
- Barnes, T.R.E. A Rating Scale for Drug-Induced Akathisia. Br. J. Psychiatry 1989, 154, 672–676. [Google Scholar] [CrossRef] [Green Version]
- Hamilton, M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 1960, 23, 56–62. [Google Scholar] [CrossRef] [Green Version]
- Kay, S.R.; Fiszbein, A.; Opler, L.A. The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia. Schizophr. Bull. 1987, 13, 261–276. [Google Scholar] [CrossRef]
- Montgomery, S.A.; Smeyatsky, N.; de Ruiter, M.; Montgomery, D.B. Profiles of antidepressant activity with the Montgomery-Asberg depression rating scale. Acta Psychiatr. Scand. 1985, 72, 38–42. [Google Scholar] [CrossRef]
- Posner, K.; Brent, D.; Lucas, C.; Gould, M.; Stanley, B.; Brown, G.; Fisher, P.; Zelazny, J.; Burke, A.; Oquendo, M.; et al. Columbia-Suicide Severity Rating Scale (C-SSRS). Available online: https://cssrs.columbia.edu/wp-content/upAloads/C-SSRS_Pediatric-SLC_11.14.16.pdf (accessed on 17 January 2023).
- Simpson, G.M.; Angus, J.W. A rating scale for extrapyramidal side effects. Acta Psychiatr. Scand. 1970, 45, 11–19. [Google Scholar] [CrossRef]
- Guy, W. Abnormal Involuntary Movement Scale (117-AIMS). In ECDEU Assessment Manual for Psychopharmacology; National Institute of Mental Health: Rockville, MD, USA, 1976; pp. 534–537. [Google Scholar]
- Young, R.C.; Biggs, J.T.; Ziegler, V.E.; Meyer, D.A. A Rating Scale for Mania: Reliability, Validity and Sensitivity. Br. J. Psychiatry 1978, 133, 429–435. [Google Scholar] [CrossRef] [PubMed]
- International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). Centers for Disease Control and Prevention: National Center for Health Statistics. Available online: https://www.cdc.gov/nchs/icd/icd9cm (accessed on 1 December 2022).
- CPT® Overview and Code Approval. American Medical Association. Available online: https://www.ama-assn.org/practice-management/cpt (accessed on 1 December 2022).
- Miotto, R.; Wang, F.; Wang, S.; Jiang, X.; Dudley, J.T. Deep learning for healthcare: Review, opportunities and challenges. Brief. Bioinform. 2017, 19, 1236–1246. [Google Scholar] [CrossRef] [PubMed]
- Belle, A.; Thiagarajan, R.; Soroushmehr, S.M.; Navidi, F.; Beard, D.A.; Najarian, K. Big Data Analytics in Healthcare. Biomed. Res. Int. 2015, 2015, 370194. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lee, J.-G.; Jun, S.; Cho, Y.-W.; Lee, H.; Kim, G.B.; Seo, J.B.; Kim, N. Deep Learning in Medical Imaging: General Overview. Korean J. Radiol. 2017, 18, 570–584. [Google Scholar] [CrossRef] [Green Version]
- Erickson, B.J.; Korfiatis, P.; Akkus, Z.; Kline, T.L. Machine Learning for Medical Imaging. Radiographics 2017, 37, 505–515. [Google Scholar] [CrossRef] [Green Version]
- Bergstra, J.; Breuleux, O.; Bastien, F.; Lamblin, P.; Pascanu, R.; Desjardins, G.; Turian, J.; Warde-Farley, D.; Bengio, Y. Theano: A CPU and GPU Math Compiler in Python. In Proceedings of the 9th Python in Science Conference (SCIPY 2010), Austin, RX, USA, 28 June–3 July 2010. [Google Scholar]
- Zenodo. Lasagne: First Release. Available online: https://zenodo.org/record/27878#.Y-DRX3YzZPY (accessed on 17 January 2023).
- Pedregosa, F.; Varoquaux, G.; Gramfort, A.; Michel, V.; Thirion, B.; Grisel, O.; Blondel, M.; Prettenhofer, P.; Weiss, R.; Dubourg, V.; et al. Scikit-learn: Machine learning in Python. J. Mach. Learn Res. 2011, 12, 2825–2830. [Google Scholar]
Features | Definition | Data Source |
---|---|---|
Hospitalization | Started from the corresponding admission date and ended at the corresponding discharge date | Admission/discharge data from the hospitalization table |
Diagnosis groups | Collapsed ICDs to the first-level categories (e.g., cardiovascular system disorder, etc.). Mental disorder group included one additional level of details (e.g., dementias, alcohol-induced mental disorders, etc.) [26] | Primary and secondary diagnostic ICD9 codes |
CPT groups | Grouped the CPT codes into seven categories (e.g., anesthesia, surgery, etc.) [27] | CPT codes |
Vitals signs | Focused on five types of vital sign standardized values of each vital sign into a score between 0 and 1, with 0 for normal value, and 1 for the most extreme value | Vital sign data |
Lab results | The top 10 most frequent lab analyses (e.g., carbon dioxide, etc.) Standardized values of each lab testing into a score between 0 and 1, with 0 meaning the population mean, and a higher score meaning farther away from the population mean | Lab data |
BD symptoms | Extracted keywords from the notes to identify BD symptoms. The keywords came from a set of instruments [18,19,20,21,22,23,24,25]. The keywords were grouped into BD symptoms. | Medical notes |
Demographics | Mean/N | STD/% |
---|---|---|
Age (Years) | 48.8 | 13.5 |
Male | 16,842 | 84.2% |
Race White | 14,673 | 73.4% |
Race Black | 3434 | 17.2% |
Race Others | 395 | 2.0% |
Race Unknown | 1498 | 7.5% |
Ethnicity Hispanics | 1072 | 5.4% |
Ethnicity Non-Hispanics | 17,896 | 89.5% |
Ethnicity Unknown | 1032 | 5.2% |
Hospitalization Type | Number of Hospitalizations | Number of Patients |
---|---|---|
All-cause | 10,961 | 5276 |
Mental | 7035 (64%) | 3659 (69%) |
Episodic mood disorders (296) | 2321 (21.2%) | 1613 (14.7%) |
Alcohol dependence syndrome (303) | 1156 (10.5%) | 737 (6.7%) |
Adjustment reaction (309) | 664 (6.1%) | 514 (4.7%) |
Schizophrenic disorders (295) | 811 (7.4%) | 450 (4.1%) |
Drug dependence (304) | 504 (4.6%) | 398 (3.6%) |
Drug-induced mental disorders (292) | 368 (3.4%) | 271 (2.5%) |
Alcohol-induced mental disorders (291) | 308 (2.8%) | 225 (2.1%) |
Depressive disorder not elsewhere classified (311) | 254 (2.3%) | 221 (2%) |
Nondependent abuse of drug (305) | 234 (2.1%) | 200 (1.8%) |
Other nonorganic psychoses (298) | 126 (1.1%) | 104 (0.9%) |
Anxiety dissociative and somatoform disorders (300) | 117 (1.1%) | 101 (0.9%) |
Non-mental | 3604 (33%) | 2158 (41%) |
Symptoms signs and ill-defined conditions (780–799) | 518 (4.7%) | 434 (4%) |
Diseases of the circulatory system (390–459) | 547 (5%) | 401 (3.7%) |
Diseases of the digestive system (520–579) | 408 (3.7%) | 321 (2.9%) |
Supplementary classification of factors influencing health status and contact with health services (v01–v91) | 352 (3.2%) | 301 (2.7%) |
Injury and poisoning (800–999) | 341 (3.1%) | 291 (2.7%) |
Diseases of the respiratory system (460–519) | 338 (3.1%) | 267 (2.4%) |
Diseases of the musculoskeletal system and connective tissue (710–739) | 186 (1.7%) | 165 (1.5%) |
Diseases of the genitourinary system (580–629) | 170 (1.6%) | 143 (1.3%) |
Endocrine nutritional and metabolic diseases and immunity disorders (240–279) | 191 (1.7%) | 130 (1.2%) |
Diseases of the nervous system and sense organs (320–389) | 140 (1.3%) | 121 (1.1%) |
Neoplasms (140–239) | 150 (1.4%) | 120 (1.1%) |
Outcome | DNN AUC | DNN Accuracy | SVM AUC | SVM Accuracy |
---|---|---|---|---|
0 vs. 1+/mort | 0.750 | 0.767 | 0.740 | 0.757 |
1− vs. 2+/mort | 0.776 | 0.867 | 0.770 | 0.861 |
2− vs. 3+/mort | 0.794 | 0.921 | 0.780 | 0.920 |
3− vs. 4+/mort | 0.806 | 0.946 | 0.796 | 0.949 |
Hospitalization Type | AUC |
---|---|
All-cause | 0.776 |
Mental | 0.779 |
Episodic mood disorders (296) | 0.765 |
Alcohol dependence syndrome (303) | 0.812 |
Adjustment reaction (309) | 0.762 |
Schizophrenic disorders (295) | 0.865 |
Drug dependence (304) | 0.824 |
Drug-induced mental disorders (292) | 0.821 |
Alcohol-induced mental disorders (291) | 0.904 |
Depressive disorder not elsewhere classified (311) | 0.811 |
Nondependent abuse of drug (305) | 0.834 |
Other nonorganic psychoses (298) | 0.711 |
Anxiety dissociative and somatoform disorders (300) | 0.701 |
Non-mental | 0.826 |
Symptoms signs and ill-defined conditions (780–799) | 0.832 |
Diseases of the circulatory system (390–459) | 0.841 |
Diseases of the digestive system (520–579) | 0.855 |
Supplementary classification of factors influencing health status and contact with health services (v01–v91) | 0.837 |
Injury and poisoning (800–999) | 0.814 |
Diseases of the respiratory system (460–519) | 0.852 |
Diseases of the musculoskeletal system and connective tissue (710–739) | 0.822 |
Diseases of the genitourinary system (580–629) | 0.854 |
Endocrine nutritional and metabolic diseases and immunity disorders (240–279) | 0.902 |
Diseases of the nervous system and sense organs (320–389) | 0.745 |
Neoplasms (140–239) | 0.772 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Shao, Y.; Cheng, Y.; Gottipati, S.; Zeng-Treitler, Q. Outcome Prediction for Patients with Bipolar Disorder Using Prodromal and Onset Data. Appl. Sci. 2023, 13, 1552. https://doi.org/10.3390/app13031552
Shao Y, Cheng Y, Gottipati S, Zeng-Treitler Q. Outcome Prediction for Patients with Bipolar Disorder Using Prodromal and Onset Data. Applied Sciences. 2023; 13(3):1552. https://doi.org/10.3390/app13031552
Chicago/Turabian StyleShao, Yijun, Yan Cheng, Srikanth Gottipati, and Qing Zeng-Treitler. 2023. "Outcome Prediction for Patients with Bipolar Disorder Using Prodromal and Onset Data" Applied Sciences 13, no. 3: 1552. https://doi.org/10.3390/app13031552